Catalysts for MSN Pharmaceuticals Inc

GLYCEROL PHENYLBUTYRATE — FDA approval

DAPAGLIFLOZIN — FDA approval

DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approval

DAPAGLIFLOZIN — FDA approval

DAPAGLIFLOZIN — FDA approval

DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN) — FDA approval

DAPAGLIFLOZIN — FDA approval

VIGABATRIN — FDA approval

BRIVARACETAM — FDA approval

BRIVARACETAM — FDA approval

BUMETANIDE — FDA approval

PREGABALIN — FDA approval

CHLORPROMAZINE HYDROCHLORIDE — FDA approval

ELTROMBOPAG OLAMINE — FDA approval

NOREPINEPHRINE BITARTRATE — FDA approval

PERAMPANEL — FDA approval

NILOTINIB HYDROCHLORIDE — FDA approval

BRIVARACETAM — FDA approval

MIRABEGRON — FDA approval

IRBESARTAN — FDA approval

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE (LINAGLIPTIN) — FDA approval

LINAGLIPTIN — FDA approval

LINAGLIPTIN AND METFORMIN HYDROCHLORIDE (LINAGLIPTIN) — FDA approval

POSACONAZOLE — FDA approval

TICAGRELOR — FDA approval

RIVAROXABAN — FDA approval

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval

POSACONAZOLE — FDA approval

VIGABATRIN — FDA approval

VIGABATRIN — FDA approval